Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1968
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1973 1
1976 1
1978 4
1979 4
1980 3
1981 1
1982 5
1983 6
1984 7
1985 4
1986 8
1987 12
1988 11
1989 22
1990 20
1991 22
1992 30
1993 37
1994 42
1995 40
1996 58
1997 52
1998 59
1999 36
2000 59
2001 62
2002 51
2003 57
2004 65
2005 55
2006 69
2007 82
2008 81
2009 92
2010 105
2011 123
2012 143
2013 192
2014 192
2015 234
2016 211
2017 205
2018 196
2019 204
2020 179
2021 193
2022 136
2023 161
2024 128
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

3,409 results

Results by year

Filters applied: . Clear all
Page 1
Thyroid Cancer: A Review.
Boucai L, Zafereo M, Cabanillas ME. Boucai L, et al. JAMA. 2024 Feb 6;331(5):425-435. doi: 10.1001/jama.2023.26348. JAMA. 2024. PMID: 38319329 Review.
This review summarizes current evidence regarding pathophysiology, diagnosis, and management of early-stage and advanced thyroid cancer. OBSERVATIONS: Papillary thyroid cancer accounts for approximately 84% of all thyroid cancers. Papillary, follicular (4%), …
This review summarizes current evidence regarding pathophysiology, diagnosis, and management of early-stage and advanced thyroid cancer
Thyroid cancer.
Cabanillas ME, McFadden DG, Durante C. Cabanillas ME, et al. Lancet. 2016 Dec 3;388(10061):2783-2795. doi: 10.1016/S0140-6736(16)30172-6. Epub 2016 May 27. Lancet. 2016. PMID: 27240885 Review.
Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new cases occurred in men and women in 2015. ...Patients with other, more rare subtypes of thyroid cancer-medullary and anaplastic-are ideally treated by p …
Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new cases occurred in men and …
Non-small-cell lung cancer.
Gridelli C, Rossi A, Carbone DP, Guarize J, Karachaliou N, Mok T, Petrella F, Spaggiari L, Rosell R. Gridelli C, et al. Nat Rev Dis Primers. 2015 May 21;1:15009. doi: 10.1038/nrdp.2015.9. Nat Rev Dis Primers. 2015. PMID: 27188576 Review.
Lung cancer is one of the most frequently diagnosed cancers and is the leading cause of cancer-related death worldwide. Non-small-cell lung cancer (NSCLC), a heterogeneous class of tumours, represents approximately 85% of all new lung cancer dia …
Lung cancer is one of the most frequently diagnosed cancers and is the leading cause of cancer-related death worldwide. …
Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities.
Zhang L, Feng Q, Wang J, Tan Z, Li Q, Ge M. Zhang L, et al. Biochim Biophys Acta Rev Cancer. 2023 Jul;1878(4):188928. doi: 10.1016/j.bbcan.2023.188928. Epub 2023 May 29. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37257629 Free article. Review.
Thyroid cancer (TC) is the most prevalent endocrine malignant tumor. Surgery, chemotherapy, radiotherapy, and radioactive iodine (RAI) therapy are the standard TC treatment modalities. However, recurrence or tumor metastasis remains the main challenge in the management of …
Thyroid cancer (TC) is the most prevalent endocrine malignant tumor. Surgery, chemotherapy, radiotherapy, and radioactive iodine (RAI …
Anaplastic Thyroid Cancer: New Horizons and Challenges.
Maniakas A, Zafereo M, Cabanillas ME. Maniakas A, et al. Endocrinol Metab Clin North Am. 2022 Jun;51(2):391-401. doi: 10.1016/j.ecl.2021.11.020. Epub 2022 May 4. Endocrinol Metab Clin North Am. 2022. PMID: 35662448 Review.
Anaplastic thyroid cancer (ATC) remains one of the most aggressive and deadliest malignancies. ...
Anaplastic thyroid cancer (ATC) remains one of the most aggressive and deadliest malignancies. ...
Anaplastic thyroid cancer: An update.
Rao SN, Smallridge RC. Rao SN, et al. Best Pract Res Clin Endocrinol Metab. 2023 Jan;37(1):101678. doi: 10.1016/j.beem.2022.101678. Epub 2022 May 27. Best Pract Res Clin Endocrinol Metab. 2023. PMID: 35668021 Review.
Anaplastic thyroid cancer (ATC) is one of the most lethal of all cancers. It is more common in women and occurs primarily in older patients. ...
Anaplastic thyroid cancer (ATC) is one of the most lethal of all cancers. It is more common in women and occurs primari
Clinical Development of BRAF plus MEK Inhibitor Combinations.
Subbiah V, Baik C, Kirkwood JM. Subbiah V, et al. Trends Cancer. 2020 Sep;6(9):797-810. doi: 10.1016/j.trecan.2020.05.009. Epub 2020 Jun 13. Trends Cancer. 2020. PMID: 32540454 Free article. Review.
Driver mutations in the BRAF gene, a key player in the MAPK pathway, are described in multiple tumor types, including subsets of melanoma, non-small cell lung cancer (NSCLC), and anaplastic thyroid cancer (ATC), making BRAF a desirable target for inhibition. …
Driver mutations in the BRAF gene, a key player in the MAPK pathway, are described in multiple tumor types, including subsets of melanoma, n …
Cancer of unknown primary.
Lee MS, Sanoff HK. Lee MS, et al. BMJ. 2020 Dec 7;371:m4050. doi: 10.1136/bmj.m4050. BMJ. 2020. PMID: 33288500 Review.
Cancers of unknown primary (CUPs) are histologically confirmed, metastatic malignancies with a primary tumor site that is unidentifiable on the basis of standard evaluation and imaging studies. ...The expanding use of next generation sequencing in advanced cancers o
Cancers of unknown primary (CUPs) are histologically confirmed, metastatic malignancies with a primary tumor site that is unidentifia
Thyroid carcinoma.
Sherman SI. Sherman SI. Lancet. 2003 Feb 8;361(9356):501-11. doi: 10.1016/s0140-6736(03)12488-9. Lancet. 2003. PMID: 12583960 Review.
Thyroid carcinomas are fairly uncommon and include disease types that range from indolent localised papillary carcinomas to the fulminant and lethal anaplastic disease. Several attempts to formulate a consensus about treatment of thyroid carcinoma have resulted in publishe …
Thyroid carcinomas are fairly uncommon and include disease types that range from indolent localised papillary carcinomas to the fulminant an …
Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer.
Nagano T, Tachihara M, Nishimura Y. Nagano T, et al. Curr Cancer Drug Targets. 2019;19(8):595-630. doi: 10.2174/1568009619666181210114559. Curr Cancer Drug Targets. 2019. PMID: 30526458 Review.
Lung cancer is the leading cause of cancer death worldwide. Molecular targeted therapy has greatly advanced the field of treatment for non-small cell lung cancer (NSCLC), which accounts for the majority of lung cancers. ...Vigorous efforts of clinician …
Lung cancer is the leading cause of cancer death worldwide. Molecular targeted therapy has greatly advanced the field of treat …
3,409 results